About Cytochroma
Mission
Business Strategy
Management Team
Board of Directors
Scientific
Advisory Board
Career Opportunities |
|
Business
Strategy:
Cytochroma intends to leverage its proven
expertise in the discovery, development and commercialization
of new Vitamin D therapies to rapidly commercialize multiple
products in large and growing markets. Key elements of the
Company’s strategy include:
- Developing lead products as new Vitamin D
prescription therapies for indications associated with CKD;
- Building
a fully-integrated pharmaceutical company, including a North
American commercialization infrastructure targeting nephrologists
and dialysis clinics;
- Leveraging the Company’s Vitamin D intellectual property
to establish a dominant position in the Company’s core
areas;
- Establishing partnerships with ex-North American
pharmaceutical companies at the appropriate times to maximize
the value of pipeline products;
- Building upon the Company’s
network of Key Opinion Leaders in nephrology and Vitamin D
therapeutics as well as proven management expertise to selectively
and opportunistically acquire new CKD product candidates; and
- Reducing
development risk and costs by out-licensing non-core product
candidates to commercialization partners worldwide.
|
|